Gene: CNFN
Official Full Name: cornifelinprovided by HGNC
Gene Summary: Predicted to be involved in keratinization. Located in cornified envelope. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24830 | CNFN Knockout cell line (HeLa) | Human | CNFN | 1:3~1:6 | Negative | Online Inquiry |
KO24831 | CNFN Knockout cell line (HCT 116) | Human | CNFN | 1:2~1:4 | Negative | Online Inquiry |
KO24832 | CNFN Knockout cell line (HEK293) | Human | CNFN | 1:3~1:6 | Negative | Online Inquiry |
KO24833 | CNFN Knockout cell line (A549) | Human | CNFN | 1:3~1:4 | Negative | Online Inquiry |
CNFN Gene Knockout Cell Lines represent a cutting-edge tool in the field of molecular biology, specifically designed to facilitate the detailed study of gene function and regulation. These cell lines are created using advanced CRISPR/Cas9 gene-editing technology, allowing for precise disruption of the CNFN gene, which is crucial in various cellular processes. The resulting knockout cell lines serve as a powerful resource for researchers seeking to uncover the gene's biological role, pathways it influences, and its implications in disease mechanisms.
The primary function of CNFN Gene Knockout Cell Lines is to provide a controlled environment for elucidating gene function through loss-of-function studies. By disabling the CNFN gene, researchers can observe phenotypic changes, cellular behaviors, and molecular interactions that arise, which aids in understanding its contribution to health and disease. This capability is particularly valuable in drug discovery and therapeutic research, where determining the impact of genetic targets is essential.
The scientific importance of these cell lines extends to various applications in both research and clinical settings. They allow for the investigation of gene therapies, elucidation of disease pathways, and development of novel pharmacological agents that target specific genetic factors. Researchers in academia and the biotech industry can leverage these cell lines to accelerate their studies, gain insights into gene-related pathologies, and contribute to the expanding knowledge of genetic disorders.
What sets CNFN Gene Knockout Cell Lines apart from existing alternatives is the precision of the CRISPR/Cas9 approach combined with comprehensive validation of gene knockout performance. This ensures not only reliability but also reproducibility in experimental outcomes, making these cell lines an indispensable resource. Moreover, the ease of use and integration into standard laboratory workflows further enhances their appeal to both novice and experienced researchers.
For researchers, clinicians, and developers in the genetic and pharmaceutical fields, CNFN Gene Knockout Cell Lines provide an invaluable asset for exploring the complexities of gene function, paving the way for innovative treatments and breakthrough discoveries. Our deep expertise in genetic technologies and commitment to providing high-quality biological products underscores our dedication to advancing scientific research and improving outcomes in medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.